Amyris (Biotechnology) Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
1,598
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
29
- Investments
-
20
Amyris (Biotechnology) General Information
Description
Manufacturer of biotechnology products intended to serve consumer and industrial markets. The company utilizes a lab-to-market technology platform combining microbial engineering, precision fermentation and machine learning, providing renewable molecules such as farnesene, squalene, squalane, bisabolol, and artemisinin, designed for the flavor, fragrance, health, and beauty sectors to deliver sustainable and high-performing chemical ingredients at scale.
Contact Information
Website
www.amyris.comCorporate Office
- 5885 Hollis Street
- Suite 100
- Emeryville, CA 94608
- United States
Corporate Office
- 5885 Hollis Street
- Suite 100
- Emeryville, CA 94608
- United States
Amyris (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Amyris (Biotechnology) Comparisons
Industry
Financing
Details
Amyris (Biotechnology) Competitors (18)
One of Amyris (Biotechnology)’s 18 competitors is Arzeda, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arzeda | Venture Capital-Backed | Seattle, WA | ||||
| Lygos | Venture Capital-Backed | Hayward, CA | ||||
| Edeniq | Venture Capital-Backed | Visalia, CA | ||||
| Manus | Venture Capital-Backed | Waltham, MA | ||||
| EvoNext Holdings | Formerly VC-backed | Reinach, Switzerland |
Amyris (Biotechnology) Patents
Amyris (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025169900-A | Compositions and methods for purification of isoprenoids | Pending | 03-May-2024 | ||
| JP-2026172899-A | Compositions and methods for the purification of isoprenoids | Pending | 03-May-2024 | ||
| US-12358856-B1 | Compositions and methods for the purification of isoprenoids | Active | 03-May-2024 | ||
| US-20250368590-A1 | Compositions and methods for the purification of isoprenoids | Pending | 03-May-2024 | ||
| WO-2025231334-A1 | Compositions and methods for the purification of isoprenoids | Pending | 03-May-2024 | B01D15/203 |
Amyris (Biotechnology) Signals
Amyris (Biotechnology) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Amyris (Biotechnology) Investments & Acquisitions (20)
Amyris (Biotechnology)’s most recent deal was a Buyout/LBO with Amyris (Manufacturing Facility in Brazil). The deal was made on 29-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Amyris (Manufacturing Facility in Brazil) | 29-May-2025 | Buyout/LBO | Buildings and Property | ||
| Aprinnova | 03-Apr-2023 | Merger/Acquisition | Specialty Chemicals | ||
| Interfaces Indústria e Comércio de Cosméticos | 16-May-2022 | Merger/Acquisition | Personal Products | ||
| Onda Beauty | 11-Apr-2022 | Merger/Acquisition | Personal Products | ||
| MenoLabs | 10-Mar-2022 | Merger/Acquisition | Other Consumer Non-Durables |
Amyris (Biotechnology) Exits (3)
Amyris (Biotechnology)’s most recent exit was on 11-Apr-2022 from Onda Beauty. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Onda Beauty | 11-Apr-2022 | Completed |
|
||
| MenoLabs | 10-Mar-2022 | Completed |
|
||
| Novvi | 01-Jan-2011 | Joint Venture | Completed |
|
Amyris (Biotechnology) Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Amyris-Olika | Emeryville, CA | 2021 | |
| Clean Beauty Collaborative | Emeryville, CA | 2020 | |
| Terrasana Management | Columbus, OH | 2017 | |
| MG Empower | London, United Kingdom | 2017 | |
| Costa Brazil | New York, NY | 2016 |
Amyris (Biotechnology) FAQs
-
When was Amyris (Biotechnology) founded?
Amyris (Biotechnology) was founded in 2003.
-
Where is Amyris (Biotechnology) headquartered?
Amyris (Biotechnology) is headquartered in Emeryville, CA.
-
What is the size of Amyris (Biotechnology)?
Amyris (Biotechnology) has 1,598 total employees.
-
What industry is Amyris (Biotechnology) in?
Amyris (Biotechnology)’s primary industry is Biotechnology.
-
Is Amyris (Biotechnology) a private or public company?
Amyris (Biotechnology) is a Private company.
-
What is Amyris (Biotechnology)’s current revenue?
The current revenue for Amyris (Biotechnology) is .
-
How much funding has Amyris (Biotechnology) raised over time?
Amyris (Biotechnology) has raised $1.67B.
-
Who are Amyris (Biotechnology)’s investors?
Pivotal Capital Partners has invested in Amyris (Biotechnology).
-
Who are Amyris (Biotechnology)’s competitors?
Arzeda, Lygos, Edeniq, Manus, and EvoNext Holdings are some of the 18 competitors of Amyris (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process